During the past decade, Rodebaugh Diabetes Center, University of Pennsylvania conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Rodebaugh Diabetes Center, University of Pennsylvania" #1 collaborator was "National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)" with 2 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Rodebaugh Diabetes Center, University of Pennsylvania" are "Hypoglycemia Unawareness" (2 trials), "Healthy" (1 trials), "Hypoglycemia" (1 trials), "Hypoglycemia Night" (1 trials) and "Nocturnal Hypoglycemia" (1 trials). Many other conditions were trialed in "Rodebaugh Diabetes Center, University of Pennsylvania" in a lesser frequency.

Most popular intervention types in "Rodebaugh Diabetes Center, University of Pennsylvania" are "Device" (2 trials). Other intervention types were less common.

The name of intervention was led by "MiniMed 670G system" (1 trials) and "RT-CGM" (1 trials). Other intervention names were less common.

The vast majority of trials in "Rodebaugh Diabetes Center, University of Pennsylvania" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Rodebaugh Diabetes Center, University of Pennsylvania". undefined are not yet recruiting, undefined are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Rodebaugh Diabetes Center, University of Pennsylvania, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Rodebaugh Diabetes Center, University of Pennsylvania, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".